Non-transcriptional action of oestradiol and progestin triggers DNA synthesis

EMBO Journal

Volumn 18, Issue 9, 1999, Pages 2500-2510

  Castoria, Gabriella ^a   Barone, Maria Vittoria ^b,c   Di Domenico, Marina ^a   Bilancio, Antonio ^a   Ametrano, Donatella ^a   Migliaccio, Antimo ^a   Auricchio, Ferdinando ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c Dipto Biol e Patol Cell e Molec   (Italy)

Author keywords

Cell cycle progression; Non transcriptional action; Oestradiol; Progestin; Raf 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANSAMYCIN DERIVATIVE; ANTIBODY; COMPLEMENTARY DNA; ESTRADIOL; ESTRADIOL RECEPTOR; ESTROGEN RECEPTOR; GELDANAMYCIN; GESTAGEN;

ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA SYNTHESIS; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROINJECTION; ONCOGENE RAS; ONCOGENE SRC; PRIORITY JOURNAL;

EID: 0033522392     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.9.2500     Document Type: Article

References (70)

1. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. and Saltiel, A.R. (1995) PD098059 is a specific inhibitor of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270, 27489-27494.
2. Auricchio, F., Di Domenico, M., Migliaccio, A., Castoria, G. and Bilancio, A. (1995) The role of estradiol receptor in the proliferative activity of vanadate in MCF-7 cells. Cell Growth Differ., 6, 105-113.
3. Avruch, J., Zhang, X.F. and Kyriakis, J.M. (1994) Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci., 19, 279-283.
4. Barone, M.V. and Courtneidge, S.A. (1996) Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature, 378, 509-512
5. 1/S arrest. Genes Dev., 8, 453-464.
6. Beato, M., Herrlich, P. and Schutz, G. (1995) Steroid-hormone receptors: many actors in search of a plot. Cell, 83, 851-857.
7. Bogunski, M.S. and McCormick, F. (1993) Protein regulating Ras and its relatives. Nature, 366, 643-654.
8. Borsch-Haubold, A.G., Pasquet, S. and Watson, S.P. (1998) Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB203580 and PD98059. SB203580 also inhibits thromboxane synthase. J. Biol. Chem., 273, 28766-28772.
9. Boyer, B., Roche, S., Denoyelle, M. and Thierry, J.P. (1997) Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J., 16, 5904-5913.
10. Campbell, S.L., Khosravi-Far, R., Rossman, K.L., Clark, G.J. and Der, C.J. (1998) Increasing complexity of Ras signaling. Oncogene, 17, 1395-1413.
11. Cantley, L.C., Auger, K.R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R. and Soltoff, S. (1991) Oncogenes and signal transduction. Cell, 64, 281-302.
12. Chalbos, D., Vignon, F., Keidar, I. and Rochefort, H. (1982) Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J. Clin. Endocrinol. Metab., 55, 276-283.
13. Coutts, A.S. and Murphy, L.C. (1998) Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res., 58, 4071-4074.
14. Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., Young, P.R. and Lee, J.C. (1995) SB203580 is a specific inhibitor of a MAP-kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett., 364, 229-233.
15. Davidson, N.E., Gelmann, E.P., Lippman, M.E. and Dickson, R.B. (1987) Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol. Endocrinol., 1, 216-223.
16. Davis, R.G. (1993) The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem., 268, 14553-14556.
17. Di Domenico, M., Castoria, G., Bilancio, A., Migliaccio, A. and Auricchio, F. (1996) Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res., 56, 4516-4521.
18. Dickson, R. and Lippman, M.E. (1995) Growth factors in breast cancer. Endocr. Rev., 16, 559-589.
19. Downward, J. (1997) Cell cycle: routine role for Ras. Curr. Biol., 7, 258-260.
20. Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J. and Saltiel, A.R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl Acad. Sci. USA, 92, 7686-7689.
21. Dufourny, B., Alblas, J., van Teeffelen, H.A.A.M., van Schaik, F.M.A., van der Burg, B., Steenbergh, P.H. and Sussenbach, J.S. (1997) Mitogenic signalling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J. Biol. Chem., 272, 31163-31171.
22. Evans, R.M. (1998) The steroid and thyroid hormone receptor superfamily. Science, 240, 889-895.
23. Fantl, V., Stamp, G., Andrews, A., Rosewell, I. and Dickson, C. (1995) Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev., 9, 2364-2372.
24. Fiddes, R.J., Janes, P.W., Sivertsen, S.P., Sutherland, R.L., Musgrove, E.A. and Daly, R.J. (1998) Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells. Oncogene, 16, 2803-2813.
25. Filmus, J., Robles, A.I., Shi, W., Wong, M.J., Colombo, L.L. and Conti, C.J. (1994) Induction of cyclin D1 overexpression by activated ras. Oncogene, 9, 3627-3633.
26. Gorski, J. (1997) Do we need new paradigms? Endocr. News, 22, 4-12.
27. Guy, C.T., Muthuswamy, S.K., Cardiff, R.D., Soriano, P. and Muller, W.J. (1994) Activation of the c-src kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev., 8, 23-32.
28. Hall, C.V., Jacob, P.E., Ringold, G.M. and Lee, F. (1983) Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J. Mol. Appl. Genet., 2, 101-110.
29. Horwitz, K.B., Mockus, M.B. and Lessey, B.A. (1982) Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell, 28, 633-642.
30. Kasid, A. and Lippman, M.E. (1987) Estrogen and oncogene mediated growth regulation of human breast cancer cells. J. Steroid Biochem., 27, 465-470.
31. Kerkhoff, E. and Rapp, U.R. (1998) Cell cycle targets of Ras/Raf signalling. Oncogene, 17, 1457-1462.
32. Khwaya, A., Lehmann, K., Marte, B.M. and Downward, J. (1998) Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J. Biol. Chem., 273, 18793-18801.
33. Korach, K.S. (1994) Insights from the study of animals lacking functional estrogen receptor. Science, 266, 1524-1527.
34. Lee, J.C. et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 372, 739-746.
35. Levenson, A.L. and Jordan V.C. (1997) MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res., 57, 3071-3078.
36. Loose-Mitchell, D.S., Chiappetta, C. and Stancel, G.M. (1998) Estrogen regulation of c-fos messenger ribonucleic acid. Mol. Endocrinol., 2, 946-951.
37. Lubahn, D.B., Moyer, J.S., Golding, T.S., Couse, J.F., Korach, K.S. and Smithies, O. (1993) Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl Acad Sci. USA, 90, 11162-11166.
38. Lydon, J.P., De Maio, F.J., Funk, C.R., Mani, S.K., Hughes, A.R., Montgomery, C.A., Jr, Shyamala, G., Conneely, O.M. and O'Malley, B.W. (1995) Mice lacking progesterone receptor exibit pleiotropic reproductive abnormalities. Genes Dev., 8, 2266-2278.
39. Mangelsdorf, D.J. et al. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
40. Marshall, C.J. (1994) MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev., 4, 82-89.
41. Marshall, C.J. (1996) Ras effectors. Curr. Opin. Cell Biol., 8, 197-204.
42. Migliaccio, A., Pagano, M. and Auricchio, F. (1993) Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7. Oncogene, 8, 2183-2191.
43. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J., 15, 1292-1300.
44. Migliaccio, A., Piccolo, D., Castoria, G., Di Domenico, M., Bilancio, A., Lombardi, M., Gong, W., Beato, M. and Auricchio, F. (1998) Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen. EMBO J., 17, 2008-2018.
45. Mulcahy, L.S., Smith, M.R. and Stacey, D.W. (1985) Requirement for ras proto-oncogene function during serum-stimulated growth of NIH3T3 cells. Nature, 313, 241-243.
46. Musgrove, E.A., Hamilton, J.A., Lee, C.S., Sweeney, K.J., Watts, C.K. and Sutherland, R.L. (1993) Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol., 13, 3577-3587.
47. Ottenhoff-Kalff, A.E., Rijksen, G., van Beurden, E.A.C.M., Hennipman, A., Michels, A.A. and Staal, G.E.J. (1992) Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res., 52, 4773-4778.
48. Pang, L., Sawada, T., Decker, S.J. and Saltiel, A.R. (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem., 270, 13585-13588.
49. Parker, M.G. and White, R. (1996) Nuclear receptors spring into action. Nature Struct. Biol., 3, 113-115.
50. Pietras, R.J. et al. (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene, 10, 2435-2446.
51. Planas-Silva, M.D. and Weinberg, R.A. (1997) Estrogen-dependent cyclinE-cdk2 activation through p21 redistribution. Mol. Cell. Biol., 17, 4059-4069.
52. Pratt, W.B. and Toft, D.O. (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev., 18, 306-360.
53. Roche, S., Koegl, M., Barone, M.V., Roussel, M.F. and Courtneidge, S.A. (1995) DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases. Mol. Cell. Biol., 15, 1102-1109.
54. Rodriguez-Viciana, P., Warne, P., Khwaja, A., Marte, B.M., Pappin, D., Das, P., Waterfield, M.D., Ridley, A. and Downward, J. (1997) Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell, 89, 457-467.
55. Rosen, N., Bolen, J., Schwartz, A.M., Cohen, P., De Seau, V. and Israel, M.A. (1986) Analysis of pp60 c-src protein kinase activity in human tumor cell line and tissues. J. Biol. Chem., 261, 13754-13759.
56. Rutherford, S.L. and Zuker, C.S. (1994) Protein folding and the regulation of signaling pathways. Cell, 79, 1129-1132.
57. Schlessinger, J. (1993) How receptor tyrosine kinases activate ras. Trends Biochem. Sci., 18, 273-275.
58. Schulte, T.W., Blagosklonny, M.V., Ingui, C. and Neckers, L. (1995) Disruption of the raf-1 hsp90 molecular complex results in destabilization of raf-1 and loss of raf-1-ras association J. Biol. Chem., 270, 24585-24588.
59. Schulte, T.W., Blagosklonny, M.V., Romanova, L., Mushinski, J.F., Monia, B.P., Johnston, J.F., Ngueyen, P., Trepel, J. and Neckers, L.M. (1996) Destabilization of raf-1 by geldanamycin leads to disruption of the raf-1-MEK-mitogen-activated protein kinase signalling pathway. Mol. Cell. Biol., 16, 5839-5845.
60. Sicinski, P. et al. (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82, 621-630.
61. Smith, M.R., DeGubicus, S.J. and Stacey, D.W. (1986) Requirement for c-ras proteins during viral oncogene transformation. Nature, 320, 540-543.
62. Supko, J.G., Hickman, R.L., Grever, M.R. and Malspeis, L. (1995) Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent. Cancer Chemother. Pharmacol., 36, 305-315.
63. Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I. and Chambon, P. (1989) The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J., 8, 1981-1986.
64. Truss, M., Chalepakis, G., Slater, E.P., Mader, S. and Beato, M. (1991) Functional interaction of hybrid response elements with wild-type and mutant steroid hormone receptors. Mol. Cell. Biol., 11, 3247-3258.
65. Twamley-Stein, G.M., Pepperkok, R., Ansorge, A. and Courtneidge, S.A. (1993) The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH3T3 cells. Proc. Natl Acad. Sci. USA, 90, 7696-7700.
66. Vignon, F., Bouton, M.M. and Rochefort, H. (1987) Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem. Biophys. Res. Commun., 146, 1502-1508.
67. Watters, J.J., Campbell, J.S., Cunnigham, M.J., Krebs, E.G. and Dorsa, D.M. (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology, 138, 4030-4033.
68. Weisz, A. and Bresciani, F. (1993) Estrogen regulation of proto-oncogenes coding for nuclear proteins. Crit. Rev. Oncogen., 4, 361-388.
69. Yen, A., Roberson, M.S., Varvayanis, S. and Lee, A.T. (1998) Retinoic acid induced mitogen-activated protein (MAP) extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res., 58, 3163-3172.
70. Ylikomi, T., Bocquel, M.T., Berry, M., Gronemeyer, H. and Chambon, P. (1992) Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J., 11, 3681-3694.